{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:25:10Z","timestamp":1790645110567,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.semradonc.2020.02.004","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T18:35:14Z","timestamp":1591122914000},"page":"242-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Challenges in Reirradiation of Intrahepatic Tumors"],"prefix":"10.1016","volume":"30","author":[{"given":"Dawn","family":"Owen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Lukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Velec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2020.02.004_bib0001","article-title":"Local control after stereotactic body radiation therapy for liver tumors","author":"Ohri","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0002","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0003","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0004","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0005","article-title":"Radiation dose-volume effects for liver SBRT","author":"Miften","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0006","unstructured":"Radiation Therapy Oncology Group: RTOG 1112: Randomized phase III study of sorafenib versus stereotactic body radiotherapy followed by sorafenib in hepatocellular carcinoma. Available at:https:\/\/http:\/\/www.rtog.org\/Portals\/0\/RTOGBroadcasts\/Attachments\/1112_master_w_update_5.7.13.pdf. Accessed November 3, 2020."},{"key":"10.1016\/j.semradonc.2020.02.004_bib0007","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0008","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.prro.2018.04.012","article-title":"Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis","volume":"8","author":"McDuff","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0009","first-page":"236","article-title":"The tolerance of gastrointestinal organs to stereotactic body radiation therapy: What do we know so far?","volume":"5","author":"Thomas","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.adro.2017.01.003","article-title":"Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma","volume":"2","author":"Koong","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0011","first-page":"343","article-title":"Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: Experience from two institutions","volume":"4","author":"Wild","year":"2013","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0012","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7785\/tcrt.2012.500261","article-title":"Re-irradiation: Outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region","volume":"11","author":"Abusaris","year":"2012","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2011.03.010","article-title":"Second re-irradiation: Efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields","volume":"99","author":"Abusaris","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1748-717X-4-55","article-title":"Reirradiation to the abdomen for gastrointestinal malignancies","volume":"4","author":"Haque","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13014-019-1309-x","article-title":"Ablative radiation therapy for locally advanced pancreatic cancer: Techniques and results","volume":"14","author":"Reyngold","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0016","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0017","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1118\/1.4948669","article-title":"Technical note: Validation and implementation of a wireless transponder tracking system for gated stereotactic ablative radiotherapy of the liver","volume":"43","author":"James","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0018","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijrobp.2018.02.010","article-title":"A prospective cohort study of gated stereotactic liver radiation therapy using continuous internal electromagnetic motion monitoring","volume":"101","author":"Worm","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.prro.2013.07.007","article-title":"Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy","volume":"4","author":"Yoon","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0021","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.adro.2018.10.003","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: Results of a phase 1 trial","volume":"4","author":"Henke","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0023","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","article-title":"A multi-institutional experience of MR-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00270-014-1008-9","article-title":"Evaluation of a thermoprotective gel for hydrodissection during percutaneous microwave ablation: In vivo results","volume":"38","author":"Moreland","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13014-018-1084-0","article-title":"Hyperfractionated abdominal reirradiation for gastrointestinal malignancies","volume":"13","author":"Hunt","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2011.09.045","article-title":"Accumulated dose in liver stereotactic body radiotherapy: Positioning, breathing, and deformation effects","volume":"83","author":"Velec","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0028","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2009.06.031","article-title":"Results of a multi-institution deformable registration accuracy study (MIDRAS)","volume":"76","author":"Brock","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2017.06.2455","article-title":"Implementing radiation dose-volume liver response in biomechanical deformable image registration","volume":"99","author":"Polan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijrobp.2018.08.031","article-title":"Patterns of local-regional failure after intensity modulated radiation therapy or passive scattering proton therapy with concurrent chemotherapy for non-small cell lung cancer","volume":"103","author":"Yang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0031","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2018.09.011","article-title":"Tumor trailing for liver SBRT on the MR-linac","volume":"103","author":"Fast","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0032","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","article-title":"Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: A phase 2 clinical trial","volume":"4","author":"Feng","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0033","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijrobp.2017.08.022","article-title":"Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy","volume":"102","author":"Mendiratta-Lala","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2018.09.004","article-title":"Magnetic resonance imaging evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: Long term imaging follow-up","volume":"103","author":"Mendiratta-Lala","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.prro.2013.10.002","article-title":"A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors","volume":"4","author":"Hong","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0036","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0037","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1200\/JCO.2013.49.9202","article-title":"Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases","volume":"31","author":"Soliman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2020.02.004_bib0038","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","article-title":"Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract","volume":"91","author":"Osmundson","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429620300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429620300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:50:25Z","timestamp":1760950225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429620300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1053429620300059"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2020.02.004","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Reirradiation of Intrahepatic Tumors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2020.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}